Posted by bigmacmj > 2020-08-14 17:40 | Report Abuse

We are stay in ASEAN.

Posted by Pengadil > 2020-08-14 17:54 | Report Abuse

Serioisly guys if u look at d chart, is the any hope left? Pse someone interpret the chart

Posted by bigmacmj > 2020-08-14 18:13 | Report Abuse

洗盤。。。

Posted by bigmacmj > 2020-08-14 18:19 | Report Abuse

Posted by Pengadil > Aug 14, 2020 5:54 PM | Report Abuse

Serioisly guys if u look at d chart, is the any hope left? Pse someone interpret the chart

---

Take a look supermax, kossan , top glove, harta chart, before flying, it will drop until touch 20 MA, then only fly.

Posted by manastha > 2020-08-14 18:29 | Report Abuse

Good support at 2.88 should go green on monday

Posted by darkangell > 2020-08-14 18:34 | Report Abuse

New norm looks like no see chart anymore,
Underwear oso lose now.

Posted by JohnFook > 2020-08-14 18:45 | Report Abuse

Technically it will test RM2.65 as to complete 50% retracement. Double hanging man and doji are strong bearish signals. RM2.65 is possible on next Monday. Buyers pool is at this level. I have been posting since Monday on this same point . Tq

Posted by JohnFook > 2020-08-14 18:48 | Report Abuse

25% retracement... sorry typo

Posted by denzadesu > 2020-08-14 18:49 | Report Abuse

pls evryone,
no need to fight over vaccine,
recent event shows that evryone know that glove and other
healthc stock overpriced,
vaccine no vaccine, dpharma is good to invenst, proved by recent quarter result.

thre are other sector to invest, dont just focus on hc and vaccine. property, tech, construction, etc. come on, dont put all in one sector.

Posted by JohnFook > 2020-08-14 18:50 | Report Abuse

But if no renewed news on fundamentals such as vaccine deal, 50% retracement will be possibly happening

Posted by JohnFook > 2020-08-14 18:56 | Report Abuse

For now GLOVE, PHARMA, GOLD AND TECH COUNTERS can cause much trouble.....focus on others till further clarity

Posted by bigmacmj > 2020-08-14 18:57 | Report Abuse

still have to wait 1 month for washing dish lah. wash until impatient guy, and short term trader left .

Posted by denzadesu > 2020-08-14 18:59 | Report Abuse

yeôa, nice, then, more will collect cheap, it doesnt matter, people will come, this is the one of counter in health care, with good fundamental, that not so much over price.

for other health care that limit up last week,
well, if other country announce their vaccine news,
i wonder.

Posted by bigmacmj > 2020-08-14 18:59 | Report Abuse

pls evryone,
no need to fight over vaccine,
recent event shows that evryone know that glove and other
healthc stock overpriced,
vaccine no vaccine, dpharma is good to invenst, proved by recent quarter result.

thre are other sector to invest, dont just focus on hc and vaccine. property, tech, construction, etc. come on, dont put all in one sector.

------

with Q2 mco period report, what sector worth for invest?

Posted by denzadesu > 2020-08-14 19:06 | Report Abuse

just find counter with good fundamental, undervalue.
when to enter, well, up to you.
just check today red sea, find with green signal, or the least dropping, but have volume. now, finding good counter is easy.

Posted by manastha > 2020-08-14 19:44 | Report Abuse

https://www.thestar.com.my/aseanplus/aseanplus-news/2020/08/14/vietnam-to-buy-russia039s-covid-19-vaccine

Posted by warrenG > 2020-08-14 20:04 | Report Abuse

I wonder if you guys actually know about the quarter report yesterday..obviously the investor are not really satisfied with the slight increase in net profit to justify the current stock price, and 0.5 cent dividend compared to 1 cent dividend previous year.

Posted by James89 > 2020-08-14 21:55 | Report Abuse

warrenG I wonder if you guys actually know about the quarter report yesterday..obviously the investor are not really satisfied with the slight increase in net profit to justify the current stock price, and 0.5 cent dividend compared to 1 cent dividend previous year

Hopefully the ‘investor’ aware that we dont have covid and mco last year. Plus the share appreciation ytd.

Posted by DuitGeli2 > 2020-08-14 22:16 | Report Abuse

https://www.marketwatch.com/story/heres-a-pandemic-stock-tip-buy-on-the-rumor-of-a-covid-19-vaccine-sell-on-the-news-2020-08-14

Posted by Louis7777 > 2020-08-14 23:11 | Report Abuse

Some Technology company still gross btr the dpharma in this COVID-19 As medical sector

Posted by Godofgambler > 2020-08-14 23:36 | Report Abuse

Novavax Inc up to date USD148.20
Year to date +3,623.62% up.
So will Duopharma follow this step?

Posted by GuanYinMa > 2020-08-15 02:53 | Report Abuse

https://www.thejakartapost.com/news/2020/08/06/canada-strikes-deals-for-vaccine-candidates-with-pfizer-moderna.html

Posted by GuanYinMa > 2020-08-15 02:53 | Report Abuse

https://worldofbuzz.com/pharmaceutical-company-pfizer-is-reported-to-have-successfully-produced-a-vaccine-for-covid-19/

Posted by Plantermen > 2020-08-15 10:04 | Report Abuse

Rotation play

Posted by Keyman188 > 2020-08-15 11:04 | Report Abuse

EU reaches deal with AstraZeneca for at least 300 million doses of potential Covid-19 vaccine

PUBLISHED FRI, AUG 14 20206:33 AM EDT

~ The European Commission has reached a deal with AstraZeneca for the purchase of at least 300 million doses of its potential Covid-19 vaccine.

~ The Commission said the deal also included an option to purchase 100 million more doses.


The European Commission said on Friday it had reached a deal with British pharmaceutical firm AstraZeneca for the purchase of at least 300 million doses of its potential Covid-19 vaccine.

The EU’s executive arm, which is negotiating on behalf of the 27 EU states, said the deal also included an option to purchase 100 million more doses should the vaccine prove safe and effective.


##https://www.cnbc.com/2020/08/14/eu-astrazeneca-vaccine-deal.html

Posted by Keyman188 > 2020-08-15 11:13 | Report Abuse

China Sinopharm's potential COVID-19 vaccine triggers antibodies in clinical trials (14 Aug 2020 04:07PM)

BEIJING: A coronavirus vaccine candidate developed by a unit of China National Pharmaceutical Group (Sinopharm) appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials, researchers said.

The potential vaccine has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval.

Sinopharm is testing the potential vaccine in the United Arab Emirates in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site.

The state-owned company will also supply the candidate to Pakistan as part of a trial agreement, the Wall Street Journal reported.

The shot did not cause any serious side effects, according to a paper published on Thursday in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes.
Advertisement

The results were based on data from 320 healthy adults in Phase 1 and 2 trials.

The candidate triggered robust antibody responses in inoculated people, but it remained unknown if that was sufficient to prevent COVID-19 infection, researchers developing the vaccine said in the paper.

Sinopharm's chairman told state media last month that a potential vaccine could be ready by the end of this year with Phase 3 testing expected to be completed in about three months.

The novel coronavirus, which has killed more than 750,000 people globally, has prompted a race to develop a vaccine. More than 150 candidate vaccines are being developed and tested around the world.

Russia became the first country to grant regulatory approval to a vaccine after less than two months of human testing, and a shot developed by Chinese firm CanSino Bilogics has been cleared for use in the military.

China is leading the development of at least eight vaccine candidates in different stages of clinical trials.



##https://www.channelnewsasia.com/news/asia/china-sinopharm-covid-19-vaccine-triggers-antibodies-trials-13020856

Posted by Keyman188 > 2020-08-15 11:21 | Report Abuse

Oxford coronavirus vaccine phase III trials to conclude by November, mass production expected by 2021

(Sun Online Desk / 14th August, 2020 03:16:50)

The University of Oxford-AstraZeneca backed novel coronavirus vaccine has been one of the leading vaccine candidates in the global race. The vaccine, currently in phase III of its trials, which was considered to be the first one to get launched for the public in 2020 will be most likely available for public deployment by 2021, according to latest reports.

Currently, phase III clinical trials are being conducted in research facilities across UK, US, Brazil and South Africa. Trials are also expected to start from next week in India in partnership with Serum Institute of India.
The Oxford University backed vaccine, called AZD-12222 was one of the first to head into the human trial stage as well as start late-stage trials. It's also one vaccine, which has found to be "safest" yet by the WHO in the pre-development phase.

Made using a non-replicating viral strain, the most recent development was confirmed by researchers from the Oxford vaccine research institute, quelling any rumours about an early advent related to launching in 2020.

With researchers hopeful of seeing the end of clinical trials by November of early December, Oxford Researchers have also signed an agreement with Mexico and Argentine authorities to scale up production in the first quarter of 2021.

Making the vaccine available for all

The University of Oxford has also signed pacts with global vaccine makers and vaccine federations. WHO also asked top vaccine makers in the race to be a part of its global vaccine alliance, COVAX to ensure equal distribution of the doses for the public.


##https://www.daily-sun.com/post/499388/Oxford-coronavirus-vaccine-phase-III-trials-to-conclude-by-November-mass-production-expected-by-2021

Posted by Keyman188 > 2020-08-15 11:54 | Report Abuse

The U.S. has already invested billions in potential coronavirus vaccines. Here’s where the deals stand

(Published Fri, Aug 14 20206:30 AM EDTUpdated Fri, Aug 14 20209:52 AM EDT)


~ So far, the federal government has struck deals with a handful of pharmaceutical giants that have topped roughly $10.79 billion as part of Operation Warp Speed.

~ The operation aims to provide at least 300 million doses of a coronavirus vaccine by January 2021.

~ Moderna, Johnson & Johnson, Pfizer and BioNTech, Sanofi and GlaxoSmithKline, Novavax and AstraZeneca have all received funding from the operation for their vaccines.


The U.S. has doled out billions to develop a vaccine against the coronavirus that has infected more than 5.1 million people across the country, locking in a minimum of 800 million doses as soon as the immunizations are cleared later this year or early next year.

So far, the deals with a handful of pharmaceutical giants have topped roughly $10.79 billion as part of Operation Warp Speed, a program led by several departments within the federal government to accelerate the development, manufacturing, and distribution of vaccines and treatments to fight the coronavirus.

The operation aims to provide at least 300 million doses of a coronavirus vaccine by January 2021. In most of the agreements, the Department of Health and Human Services says the vaccines will be given to the American people for free if part of a vaccine campaign. Once the vaccines are approved, the campaign is intended to quickly deliver them to as many people as possible. The federal government has said it will cover the cost of delivery but health-care providers can charge to administer the vaccine.

“It is likely that at the beginning of next year we would have tens of millions of doses available,” Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told reporters on a conference call alongside National Institutes of Health Director Dr. Francis Collins on July 27.

“I think as we get into 2021, several months in, that you would have vaccines that would be widely available,” Fauci said.

Experts say some of the top vaccine candidates are already being manufactured “at risk,” meaning the doses are created and prepared for deployment before official approval from the U.S. Food and Drug Administration.

“We are investing in the development and manufacture of the top six vaccine candidates to ensure rapid delivery. The military is ready to go, they’re ready to deliver a vaccine to Americans as soon as one is fully approved by the FDA and we’re very close to that approval,” President Donald Trump said during a news conference at the White House on Tuesday.

The U.S. is only obligated to pay the next tranche of funding if the vaccines are cleared by the Food and Drug Administration.


Cont....



##https://www.cnbc.com/2020/08/14/the-us-has-already-invested-billions-on-potential-coronavirus-vaccines-heres-where-the-deals-stand.html

Posted by Keyman188 > 2020-08-15 12:02 | Report Abuse

Keyman188 foresee a lot of traders & investors will be surprised by this 2 core pharmaceutical firms which dealing with Covid-19 vaccine will be reaching unprecedented level :-

1) Pharma - TP 10.00

2) Dpharma - TP 7.50


Keyman188 looking at long term growth due to following reason (which were highlighted by Minister) :-


1) Two government-linked companies (GLC) which are also pharmaceutical manufacturing facilities have been identified to do the "fill and finish" process for the Covid-19 vaccine once it's available


2) "The two companies have told the government that they are willing to take stock production and prioritise it for the Covid-19 vaccine when it is available.


3) If we have the capacity, we will also offer our fill and finish service to other countries.



^^^ The main profitable driven coming for the next 3 years by vaccine needed at mass market


---------------------------------------------------------------------------------------------------


A lot of investors & traders not review the past annual report for Duopharma

Gross Profit margin always can generated by 40% from the revenue

Net profit also improved by 11% to 13% since 2018

Forthcoming financial performance more & more bright of this pharmaceutical firm since already appointed core company dealing with Covid-19 vaccine once available


---------------------------------------------------------------------------------------------------



@@ Keyman188 always like to repeat & repeat to remind "old people" like Keyman188 to avoid forgotten........

Posted by James89 > 2020-08-15 12:08 | Report Abuse

Good sharing Keyman188. Cheers!

Posted by iluveu28 > 2020-08-15 12:20 | Report Abuse

but why EPF kept selling?

Posted by mnajib57 > 2020-08-15 12:28 | Report Abuse

thats how epf earn money. if you know how epf style in investment you will know. :). in the end the price push higher. look how they do with kossan.

Posted by James89 > 2020-08-15 12:47 | Report Abuse

Note that EPF is not a charity fund. How to profit if forever acquire without releasing.

Posted by supersinginvestor > 2020-08-15 14:06 | Report Abuse

Epf fund managers got to show performance or no job ok...so they will sell once up. Then they will stop selling...
Once they stop then pricr will go all the way up. Its a complicated process. Easiest i can explain is above..

Posted by supersinginvestor > 2020-08-15 14:07 | Report Abuse

duopharma n pharma will come down abit more then up but gloves are over and done with...

Posted by brucechun > 2020-08-15 14:09 | Report Abuse

Modi promises locally-made Covid-19 vaccine for all Indians


(Aug 15): India has three Covid-19 vaccines under trial and will ensure a vaccine reaches every citizen, Prime Minister Narendra Modi said, paying tribute to those fighting the coronavirus pandemic that’s surging across India.

India is racing to produce an indigenous vaccine. Bharat Biotech International Ltd., an unlisted Indian vaccine maker, received regulatory approval to start human clinical trials for its experimental shot from India’s apex medical research body. News reports say the vaccine will be ready for stage 2 human trials in September. Zydus Cadila and Serum Institute of India also have vaccines under trial.

Once a vaccine is approved, “the road map for its production and distribution among Indians is also ready,” Modi said.

https://www.theedgemarkets.com/article/modi-promises-locallymade-covid19-vaccine-all-indians

Posted by JohnFarmer458 > 2020-08-15 14:21 | Report Abuse

14-Aug-2020 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 135,500 shares on 11-Aug-2020.
13-Aug-2020 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 940,100 shares on 10-Aug-2020.
11-Aug-2020 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 260,500 shares on 06-Aug-2020.
10-Aug-2020 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 1,500,000 shares on 05-Aug-2020.
10-Aug-2020 Insider EMPLOYEES PROVIDENT FUND BOARD (a substantial shareholder) disposed 300,000 shares on 05-Aug-2020.

EPF disposing and moving to Supermax

Posted by tingpangeng > 2020-08-15 14:29 | Report Abuse

Hi, such a big fund house only sell few hundred lots where medium net worth individuals are capable to is not something to be alarming.

Posted by Jack Khan > 2020-08-15 16:19 | Report Abuse

https://www.freemalaysiatoday.com/category/nation/2020/08/15/get-onboard-vaccine-initiative-russia-tells-malaysia/
russian tell Malaysia to get onboard vaccine initiative

Posted by Godofgambler > 2020-08-15 16:57 | Report Abuse

Glove counters finish...
Russia starts vaccine productions..

Posted by denzadesu > 2020-08-15 18:45 | Report Abuse

put some in, or just njoy the shw,
go on, pour some more ngtve cmment,
qrter results & nws will prove otherwise.
if u feel the prce now is ovr and spculated,
go on by other healthcare cnter

Posted by Keyman188 > 2020-08-15 22:37 | Report Abuse

Russia produces first batch of COVID-19 vaccine - Interfax

WORLD

Saturday, 15 Aug 2020 4:30 PM MYT

MOSCOW (Reuters) - Russia has produced the first batch of its new vaccine for COVID-19, the Interfax news agency quoted the health ministry as saying on Saturday, hours after the ministry reported the start of manufacturing.

powered by Rubicon Project

Some scientists said they fear that with this fast regulatory approval Moscow may be putting national prestige before safety amid the global race to develop a vaccine against the disease.

Russia has said the vaccine, the first for the coronavirus to go into production, will be rolled out by the end of this month.

Its approval comes before trials that would normally involve thousands of participants, commonly known as Phase III. Such trials are usually considered essential precursors for a vaccine to secure regulatory approval.

The vaccine has been named "Sputnik V" in homage to the world's first satellite launched by the Soviet Union. President Vladimir Putin has assured the public that it is safe, adding that one of his daughters had taken it as a volunteer and felt good afterwards.

Moscow's Gamaleya Institute, which developed the vaccine, said previously that Russia would be producing about 5 million doses a month by December-January, Interfax said.

(Reporting by Polina Devitt; editing by Ros Russell)



##https://www.thestar.com.my/news/world/2020/08/15/russia-starts-production-of-covid-19-vaccine---interfax

Posted by Louis7777 > 2020-08-15 23:24 | Report Abuse

Qoq and yoy increase 8%++ and 5%++ , share price aldy up almost 100% from rm1.6++ , Russian vaccine? When Malaysia will get it? Even Russian register vaccine news out dpharma still not going up but down, pure goreng guy. When u r still able to run the run, I sold at 3.5 after glove counter jump, this is the next

Posted by Sean Eng Kwong Howe > 2020-08-15 23:26 | Report Abuse

https://www.facebook.com/kementeriankesihatanmalaysia/?__tn__=kC-R&eid=ARAvgx6vyadvbVdoXj_fq3JZyPtnv7FPpWVaS66VH_ArS_MId_JUDRPtmWrlEZXDRFcKxhYYsaXFze-1&hc_ref=ARR6pjq5CjhwfbBSvTQKKCgKt3KKsY5WXLh-7puEO0ppGUSDsTmpSeWkHi2VuoHHmFQ&fref=nf&__xts__[0]=68.ARC_cmblzDbKlNaHKqCegtjFv2lgJvFt40_kuwOFQad5fmUxdm0a3BHsVuAFnXRoKVwfMViMXbLx7BX6isX7y1ZHyt0a_d_m28YVh1n3w1mbwcwZumTxsNzJJGKsIlYGFrnSVyBmAj1YNdhbOdq1wQzVtpX63qIG26gcj8hOyrZm35EOkQMilWXttbeYrlz7TS0VrcErDWOBEwA8XK0xPof5tNMEdABMwystLAzbge1Q-GtLVW8cExWmsuU0O0jSyMNcTBKZFnlomj_WCEr5fVsQL7ma8JVyXcMBdcNx0i2wGyaN0u5Q9Xk8lX0Un_TG6jMNUCBHiyQM57Vu3CpduJ9gmeIhV2XgOVpk8zIa8xQje1rwZQ

Posted by noobfuck > 2020-08-16 00:02 | Report Abuse

(1) Vaccine from Russia (not recognized),
(2) Negative 17% GDP expected already (due to MCO)
(3) Contra ban for glove counters (Fake news). Koon Yew Yin said it is to make us ikan bilis feel nervous and make panic selling for them to collect cheap.
Please invest in glove share!!

Posted by Jackthejeep > 2020-08-16 00:08 | Report Abuse

friend, have you forgotten about Indonesia, China and US? For 3) it's not fake news, brokerage firms expect glove counters to fall, dont try to mislead people

Posted by noobfuck > 2020-08-16 00:12 | Report Abuse

Friend, even you inject the vaccine, did you need a glove?
YES RIGHT?
1 patient 1 glove maybe you like to share glove then that's your business. But for hygiene and safety, glove is necessity so can you imagine how many billion of glove will be use?

Posted by beginner > 2020-08-16 00:22 | Report Abuse

you sure vaccine injection need glove, my own experience dr just inject only without glove. dont believe, go to any clinic and ask the injection for hepatitis a or b. only the needle must be new, there is no need for dr to use glove at all....

Posted by beginner > 2020-08-16 00:23 | Report Abuse

from google:

Occupational Safety and Health Administration (OSHA) regulations do not require gloves to be worn when administering vaccinations, unless persons administering vaccinations have open lesions on their hands or are likely to come into contact with a patient's body fluids (2).

Posted by darkangell > 2020-08-16 00:26 | Report Abuse

Tiu buy or not is ur own decision